A new natural history of charcot foot: Clinical evolution and final outcome of stage 0 charcot neuroarthropathy in a tertiary referral diabetic foot clinic

Clinical Nuclear Medicine

Volumn 38, Issue 7, 2013, Pages 506-509

  Ruotolo, Valeria ^a   Di Pietro, Barbara ^a   Giurato, Laura ^a   Masala, Salvatore ^a   Meloni, Marco ^a   Schillaci, Orazio ^a   Bergamini, Alberto ^b   Uccioli, Luigi ^a  

^a Department of Internal Medicine ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

18F FDG PET CT; Charcot foot; Diabetes; Inflammatory process of Charcot foot

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CHARCOT FOOT; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; FOOT DISEASE; FOOT RADIOGRAPHY; HUMAN; MALE; NEUROPATHIC JOINT DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER;

DIABETIC FOOT; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOOT JOINTS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REFERRAL AND CONSULTATION; SKIN TEMPERATURE; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84880379016     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318292eecb     Document Type: Article

References (27)

1. Sanders LJ, Frykberg RG. Charcot Neuroarthropathy of the Foot. The Diabetic Foot (6th edn). St Louis, MO: Mosby; 2001:21.
2. Eichenholtz, SN. Charcot Joint. Springfield: C.C. Thomas; 1996.
3. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg. 1990;72A:749-756.
4. Armstrong DG, Todd WF, Lavery LA, et al. The natural history of acute Charcot's arthropathy in a diabetic foot speciality clinic. Diabet Med. 1997;14: 357-363.
5. Edmonds ME, Petrova N, Elias D. The earliest magnetic resonance imaging sign of mid-foot Charcot osteoarthropathy is oedema of the subchondral (subarticular) bone marrow which needs prompt therapeutic offloading. Diabetic Med. 2005;22(suppl 2):93(abstract).
6. Chantelau E, Poll L. Evaluation of the diabetic Charcot foot by MR imaging or plain radiographyVan observational study. Exp Clin Endocrinol Diabetes. 2006;114:428-431.
7. Edmonds ME, Watkins PJ. The Charcot joint: Understanding its natural history leads to new treatment and prevention. Diabetic Med. 1984;1:144(Abstract).
8. Giurini JM, Chrzan JS, Gibbons GW, et al. Charcot's disease in diabetic patients. Correct diagnosis can prevent progressive deformity. Postgrad Med. 1991;89:163-169.
9. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38:34-40.
10. Yu GV, Hudson Jr. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;94:210-220.
11. Chantelau E. The perils of procrastination: Effects of early vs delayed detection and treatment of incipient Charcot fracture. Diabetic Med. 2005;22: 1707-1712.
12. Kimmerle R, Chantelau E. Weight-bearing intensity produces Charcot deformity in injured neuropathic feet in diabetes. Exp Clin Endocrinol Diabetes. 2007;115:360-364.
13. World Health Organization. Second Report on Diabetes Mellitus. Geneva:World Health Organization; 1980.
14. Bacharach J, Rooke T, Osmundson P, et al. Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg. 1992;15:558-563.
15. LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes. N Engl J Med. 1984;311:1615-1619.
16. Carter S. Elective foot surgery in limbs with arterial disease. Clin Orthop. 1993;289:228-236.
17. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317-321.
18. Israel O, Keidar Z, Iosilevsky G, et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med. 2001;31:191-205.
19. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007; 28:465-472.
20. Pickwell KM, van Kroonenburgh MJ, Weijers RE, et al. F-18 FDG PET/TC scanning in Charcot Disease. A brief report. Clin Nucl Med. 2011;36:8-10.
21. Schlossbauer T, Mioc T, Sommerey S, et al. Magnetic resonance imaging in early stage Charcot arthropathy: Correlation of imaging findings and clinical symptoms. Eur J Med Res. 2008;22:409-414.
22. Classen JN, Rolley RT, Carneiro R, et al. Management of foot conditions of the diabetic patient. Am Surg. 1976;42:81-88.
23. Chantelau E, Richter A, Ghassem-Zadeh N, et al. ''Silent'' bone stress injuries in the feet of diabetic patients with polyneuropathyVa report of 12 cases. Arch Orthop Trauma Surg. 2007;127:171-177.
24. Chantelau E, Richter A, Schmidt-Grigoriadis P, et al. The diabetic Charcot foot: MRI discloses bone stress injuries as trigger mechanism of neuroarthropathy. Exp Clin Endocrinol Diabetes. 2006;114:118-123.
25. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34:2123-2129.
26. Fedele D, Comi G, Coscelli C, et al. A multi center study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care. 1997;20:836-843.
27. Perrin BM, Gardner MJ, Suhaimi A, et al. Charcot osteoarthropathy of the foot. Aust Fam Physician. 2010;38:117-119.